Literature DB >> 9145265

Discrepancy in patch test results with wool wax alcohols and Amerchol L-101.

L Matthieu1, P Dockx.   

Abstract

Wondering why Amerchol L-101 (containing wool wax alcohols obtained from the hydrolysis of wool fat) appears as a test material (100%) in a cosmetics series (Chemotechnique Diagnostics AB), as wool wax alcohols were already tested in the European standard series, we added Amerchol L-101 (100%) systematically to the standard series. From 8 April 1991 to 28 February 1992, a total of 393 patients were tested: 3.05% (n = 12) showed positive test results (+, +2, +3) for wool wax alcohols as well as Amerchol L-101 (100%), 0.3% (n = 1) for wool wax alcohols only, and 11.1% (n = 44) for Amerchol L-101 (100%) only. Thus, the positive tests for Amerchol L-101 (100%) had a higher frequency of 3.4 compared to those for wool wax alcohols. In the meantime, we also added Amerchol L-101 50% (Trolab) to the standard series. Of all patients tested (n = 223) 2.7% (n = 6) had positive reactions to wool wax alcohols and 12.1% (n = 27) to Amerchol L-101 100% and/or 50%. Thus, positive reactions to Amerchol L-101 (100% and 50%) were 4.5 higher, whereas the rate of concordancy decreased. It is remarkable that 8 patients only had a positive reaction to Amerchol L-101 50% and 9 only to Amerchol L-101 100%. It seems that we miss many diagnoses in contact allergy by using only the standard wool wax alcohols test (30%).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145265     DOI: 10.1111/j.1600-0536.1997.tb00398.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  4 in total

1.  Invited commentary: recommendation for a north american pediatric patch test series.

Authors:  Sharon E Jacob; Shehla Admani; Elise M Herro
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

2.  Diagnosing lanolin contact allergy with lanolin alcohol and Amerchol L101.

Authors:  Jannet Knijp; Derk P Bruynzeel; Thomas Rustemeyer
Journal:  Contact Dermatitis       Date:  2019-03-19       Impact factor: 6.600

3.  Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD),.

Authors:  Jodie Raffi; Raagini Suresh; Harvey Fishman; Nina Botto; Jenny E Murase
Journal:  Int J Womens Dermatol       Date:  2019-11-07

4.  Clinical relevance of positive patch test reactions to lanolin: A ROAT study.

Authors:  Ada Uldahl; Malin Engfeldt; Cecilia Svedman
Journal:  Contact Dermatitis       Date:  2020-10-05       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.